Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)-Reference-Cited by-同舟云学术

Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Published:2020-09-24 Issue:20 Volume:63 Page:11639-11662
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Beck Hartmut¹^ORCID,Thaler Tobias¹,Meibom Daniel¹,Meininghaus Mark¹,Jörißen Hannah¹,Dietz Lisa¹,Terjung Carsten¹,Bairlein Michaela¹,von Bühler Clemens-Jeremias¹,Anlauf Sonja¹,Fürstner Chantal¹,Stellfeld Timo²,Schneider Dirk¹,Gericke Kersten M.¹,Buyck Thomas¹,Lovis Kai¹,Münster Uwe¹,Anlahr Johanna¹,Kersten Elisabeth¹,Levilain Guillaume¹,Marossek Virginia¹,Kast Raimund¹

Affiliation:

1. Research & Development, Pharmaceuticals, Bayer AG, 42096 Wuppertal, Germany

2. Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00834

Reference84 articles.

1. Idiopathic Pulmonary Fibrosis

2. Idiopathic pulmonary fibrosis